Trial · NCT05244304
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To measure change in atrophic lesion size (definitely decreased autofluorescence, DDAF) by fundus autofluorescence (FAF) photography from baseline | Baseline thru month 24 | |
| Secondary | To measure the change in retinal thickness assessed by spectral-domain optical coherence tomography (SD-OCT) from baseline | Baseline thru month 24 | |
| Secondary | To measure the change in retinal morphology assessed by spectral-domain optical coherence tomography (SD-OCT) from baseline | Baseline thru month 24 | |
| Secondary | To measure change in BCVA (Best Corrected Visual Acuity) score measured by the EDTRS method from baseline | Baseline thru month 24 | |
| Secondary | To measure change in plasma concentration of RBP4 levels (μM) from baseline | Baseline thru month 24 | |
| Secondary | The correlation between change in plasma RBP4 level and the rate of lesion size growth (definitely decreased autofluorescence, DDAF) by fundus autofluorescence (FAF) photography from baseline | Baseline thru month 24 | |
| Secondary | To assess the systemic and ocular safety and tolerability of tinlarebant | Baseline thru month 24 | Frequency, duration, and severity of AEs |
| Other | To measure change in total decreased autofluorescence (DAF) by FAF photography from baseline | Baseline thru month 24 | |
| Other | To measure change in questionably decreased autofluorescence (QDAF) by FAF photography from baseline | Baseline thru month 24 | |
| Other | To measure change in quantitative autofluorescence (qAF) level from baseline | Baseline thru month 24 | |
| Other | To measure change in retinal sensitivity by microperimetry from baseline | Baseline thru month 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05244304/registered